LLYQ2 20261/5Estimate vs Actual
Earnings per Share
$8.38
+ 27.0% vs Estimate
Surprise as recorded in the analysis; the estimate itself is not on the calendar.
Eli Lilly and Co Q2 2026 · Story
Read the quarter card by card, ready to share.
LLYQ2 20261/5LLYQ2 20262/5Guidance
Full-Year Revenue
- Company Guidance
- 85 – 87 billion
- Market Estimate
- 85.3 billion
Raised 3.0% ▲
Full-Year Adjusted EPS
- Company Guidance
- 35.5 – 36.5 $
Top End Cut from $37.00 ▼
Full-Year Performance Margin
- Company Guidance
- 49.0% – 50.5%
Raised 2.0 pts ▲
LLYQ2 20263/5Price Reaction
First Full Session
+ 4.9%
From the prior close to the report-day close.
LLYQ2 20264/5In 30 Seconds
Revenue rose 48% year over year to $22.97B; adjusted EPS of $8.38 beat the estimate by 27%.
- Full-year revenue guidance was raised to $85-87B, but realized prices fell 13% year over year.
- The stock rose 4.86% on earnings day; Foundayo's slow $98M start capped the enthusiasm.
First point of the analysis's “In 30 Seconds”.
Full AnalysisLLYQ2 20265/5Score
85/ 100
ViewBUY
Not Investment Advice